Applied Immune Technologies
Haifa
About Applied Immune Technologies
Applied Immune Technologies Ltd. engages in development of therapeutic molecules for cancer, viral, and autoimmune diseases. The company develops T-Cell Receptor-Like (TCRL) antibodies that are targeted to intracellular-derived peptides for various therapeutic and diagnostic applications. Its TCRL antibodies also have diagnostic applications in pathology; and vaccine design, validation, and monitoring, as well as in the analysis of antigen presentation in disease. The company was formerly known as BioMimic Pharma. The company was founded in 2006 and is based in Haifa, Israel.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Total funding: $4.0M
- Funding stage: M&A
- Last round: Series Unknown (Apr 2010)
- Website: tcrl.co.il
- Phone: +972-4-8122216
Industries & Categories
Biotechnology, Health Diagnostics, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/applied-immune-technologies-1774418 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.